Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc Analyst and Investor Call to Discuss Proposed Acquisition of Seagen Inc Call Transcript

Mar 13, 2023 / 12:00PM GMT
Operator

Good day, everyone, and welcome to Pfizer's Analyst and Investor Call to discuss proposed acquisition of Seagen. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Thank you for joining our call today on short notice. Today's call will last approximately 60 minutes. We will start with some prepared remarks followed by a question-and-answer session. Before I begin, let me remind you that Pfizer and Seagen will be making forward-looking statements during the course of this call that are subject to substantial risks and uncertainties. We undertake no obligation to update those statements and any comments we make are valid only as of today. For additional information, please see the press release regarding the proposed transaction that we issued today and the SEC Form 10-Q and 10-K filings with the companies in the sections entitled Risk Factors and Forward-Looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot